Contraception for Specific Populations

FSRH CEU Statement: Contraception for Women with Eating Disorders - May 2018

29 May 2018

Sexually active women of reproductive age with eating disorders require effective contraception despite the fact that amenorrhoea and anovulation are common in this population. This statement provides clinicians with a resource for best helping women with eating disorders choose the most appropriate and acceptable contraception for them. Download the document here.

This document is up-to-date

CEU Statement: Management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants - March 2017

29 March 2017

This statement aims to encourage the consistent and safe management of women requesting intrauterine contraception (IUC) and subdermal implants (SDI) who are taking anticoagulants or antiplatelet medications. It is primarily aimed at clinicians working in primary care and community sexual and reproductive health clinics.

This document is up-to-date

CEU Statement: Contraceptive Options for Women with Prolactinoma (September 2012)

01 September 2012

A prolactinoma is a benign pituitary gland tumour that results in the over production of prolactin (hyperprolactinaemia). Microprolactinomas are small and measure less than 10mm. Those measuring more than 10mm are known as macroprolactinomas. Symptoms of prolactinoma are caused by too much prolactin or from the pressure of a macroprolactinoma on surrounding tissues.

This document is up-to-date